ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,653Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 2343

$1.08M Total Retail Price of All Prescriptions

Rank: 93 out of 2343

687 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 687 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 687 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 14,923 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 932 659 1 1
LISINOPRIL 928 578 2 3
LEVOTHYROXINE SODIUM 895 706 3 2
HYDROCODONE-ACETAMINOPHEN 892 544 S3 4 13
OMEPRAZOLE 865 447 5 4
FUROSEMIDE 754 571 6 6
METFORMIN HCL 685 507 7 9
AMLODIPINE BESYLATE 677 510 8 5
METOPROLOL TARTRATE 577 424 9 7
ATENOLOL 539 409 10 12
WARFARIN SODIUM 421 348 11 8
POTASSIUM CHLORIDE 388 247 12 18
ATORVASTATIN CALCIUM 351 255 13 10
PANTOPRAZOLE SODIUM 317 226 14 22
HYDROCHLOROTHIAZIDE 302 206 15 11
TRIAMTERENE-HCTZ 276 218 16 57
KLOR-CON 8 272 258 17 226
AZITHROMYCIN 248 161 18 39
DIOVAN 224 204 19 23
GLYBURIDE 223 193 R 20 62
CLOPIDOGREL 216 165 21 26
CITALOPRAM HBR 213 141 22 17
CARVEDILOL 211 136 23 27
ISOSORBIDE MONONITRATE ER 206 152 24 32
GABAPENTIN 205 114 25 16
TRAMADOL HCL 194 104 26 25
PROAIR HFA 191 99 27 86
AMOXICILLIN 184 78 28 118
ALLOPURINOL 182 136 29 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 165 113 30 42
IBUPROFEN 161 88 31 75
PLAVIX 156 124 32 38
METOPROLOL SUCCINATE 146 110 33 14
DIGOXIN 137 103 34 35
RANITIDINE HCL 136 87 35 43
GLIPIZIDE 135 77 36 56
ADVAIR DISKUS 133 92 37 34
GLIPIZIDE XL 132 97 38 84
GEMFIBROZIL 131 79 39 133
VENTOLIN HFA 131 58 39 79
SPIRIVA 129 88 41 48
KLOR-CON M20 125 86 42 44
PREDNISONE 124 97 43 37
SPIRONOLACTONE 124 84 43 65
DONEPEZIL HCL 122 122 45 21
SERTRALINE HCL 122 93 45 20
PRAVASTATIN SODIUM 118 84 47 15
QUINAPRIL HCL 118 84 47 73
LANTUS 108 79 49 51
DIOVAN HCT 108 96 49 63
NEXIUM 107 84 51 33
INSULIN SYRINGE 107 72 51 102
FAMOTIDINE 98 42 53 60
TAMSULOSIN HCL 94 61 54 29
JANUVIA 92 81 55 50
ENALAPRIL MALEATE 89 67 56 58
PROPRANOLOL HCL 89 63 56 132
TRIAMCINOLONE ACETONIDE 84 52 58 137
CLOTRIMAZOLE-BETAMETHASONE 76 49 59 127
VESICARE 74 49 60 145
DETROL LA 74 70 60 150
MIRTAZAPINE 74 59 60 41
PHENYTOIN SODIUM EXTENDED 73 42 63 152
CRESTOR 73 59 63 30
DILTIAZEM 24HR ER 72 47 65 76
ALENDRONATE SODIUM 70 55 66 28
PRANDIN 67 29 67 140
RISPERIDONE 65 43 68 61
GLIMEPIRIDE 64 51 69 45
CIPROFLOXACIN HCL 63 41 70 72
TRAZODONE HCL 61 17 71 53
NAMENDA 61 50 71 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 45 73 120
SYNTHROID 58 19 74 40
METOLAZONE 57 32 75 173
PEN NEEDLE 55 23 76 119
NITROGLYCERIN PATCH 54 31 77 147
THEOPHYLLINE ANHYDROUS 53 47 78 231
MECLIZINE HCL 53 51 78 103
LEVOFLOXACIN 52 32 80 106
AMLODIPINE BESYLATE-BENAZEPRIL 51 16 81 59
FLOVENT HFA 51 39 81 213
NIASPAN 50 50 83 141
AMOX TR-POTASSIUM CLAVULANATE 50 39 83 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.